Table 3.
Characteristics of migraine patients.
| Cohort N = 77 | Lidocaine N = 45 | Ketamine N = 32 | ||
|---|---|---|---|---|
| Mean age (SD) | 42 (14.9) | 42.4 (15.8) | 41.6 (13.5) | p = 0.814 |
| Female n (%) | 67 (87%) | 37 (82.2) | 30 (93.8) | |
| Chronic migraine n (%) | 70 (90.9%) | 39 (86.7%) | 31 (96.9%) | |
| Elective infusions n (%) | 53 (68.8%) | 28 (62.2%) | 25 (78.1%) | |
| Status migrainosus n (%) | 26 (33.8%) | 16 (35.6%) | 10 (31.3%) | |
| MOH n (%) | 30 (39.0%) | 18 (40%) | 12 (37.5%) | |
| Mean comorbidities (SD) | 3.4 (2.6) | 2.9 (2.3) | 4.1 (2.9) | p = 0.049 |
| Mean failed preventive treatments (SD) | 7.5 (4.1) | 6.4 (3.8) | 8.9 (4.1) | p = 0.037 |
| Mean Duration infusion (days, SD) | 5.8 (2.1) | 6.2 (2.4) | 5.1 (1.5) | p = 0.017 |
MOH, medication overuse headache.